First Short-Term Follow-Up of Mistral Tricuspid Valve Repair Finds Significant Improvement in Severe TR
A short-term follow-up of the first-in-human study for the Mistral tricuspid valve repair device found that patients with severe tricuspid regurgitation (TR) – a group with no standard-of-care options – had significant improvements in their condition.